Thursday morning newsbrief, Dec 21 2017

Thursday morning brief Dec 21 2017
Good morning!
Here’s everything you need to know to start your day…
India has signed an agreement with Myanmar to aid development in its Rakhine province. India will spend $25 million over five years to develop the backward province. The agreement helps Myanmar work a way out of the mess in Rakhine, and Bangladesh to send back some of the refugees. It also gives India an important foothold in a country where China has recently redoubled its efforts. Read
Gift your children a great upbringing.
When your children grow up here, the difference shows. Ready flats @ 38 lakhs.

Recommended by Colombia
A special CBI court will pronounce the verdict in the 2G spectrum allocation scam today. The case involves probes by several agencies like the CAG, CBI, ED and the Central Vigilance Commission, and has several high profile politicians and bureaucrats named as accused. Former telecom minister A Raja figures prominently in the case. The charges against Raja, if proved, can fetch him life imprisonment.
The Pakistan army chief urged the country’s lawmakers to make an effort to improve relations with India. He assured that the efforts would be fully backed by the army. His address came in the backdrop of sustained American emphasis to Pakistani leadership on mending ties with India. The offer was particularly significant given a general perception that the army was against peace efforts with India.
Change the way you see your blood sugar

Recommended by Colombia
A CBI probe has been ordered against Delhi’s Adhyatmik Vishwa Vidyalaya and its founder Virender Dev Dixit. This follows revelations that more than 100 women and minor girls were locked up behind metal doors in ‘animal-like conditions,’ with many being sexually exploited for years, inside the fortress-like ashram. A PIL filed by an NGO had alerted the court to the plight of the inmates of the ashram.
Syringe manufacturers have been asked to limit margins and MRP, or the government would have to step in to regulate. In a meeting with National Pharmaceutical Pricing Authority, manufacturers suggested a cap of 75% on trade margins between ex-factory or import prices and the MRP. This comes after a recent probe into the billing practices of a private hospital found that it charged exorbitantly on medical consumables, scheduled and non-scheduled drugs.
Copyright @ 2017 Bennett, Coleman & Co. Ltd.

Leave a Reply